FMP
VolitionRx Limited
VNRX
AMEX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
0.484 USD
-0.01 (-2.07%)
VNRX Financial Statements
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Total Revenue
191.66k
474.52k
395.8k
171.53k
Cost of Revenue
0
0
323.8k
322.07k
Gross Profit
191.66k
474.52k
72k
-150.54k
Operating Expenses
5.97M
6.34M
7.06M
8.23M
Research and Development
2.59M
3.47M
3.72M
4.37M
Selling, General & Administrative Expenses
3.33M
2.87M
3.62M
3.87M
Selling & Marketing Expenses
215.13k
1.05M
165.14k
251.06k
General & Administrative Expenses
3.12M
1.82M
3.45M
3.62M
Other Expenses
51.59k
0
-273.41k
0
Operating Income
-5.78M
-5.87M
-6.99M
-8.38M
Total Other Income/Expenses Net
-75.89k
129
-69.76k
-87.5k
Income Before Tax
-5.86M
-5.87M
-7.06M
-8.47M
Income Tax
0
0
0
-104.62k
Net Income
-5.79M
-5.82M
-6.99M
-8.37M
Basic EPS
-0.07
-0.07
-0.08
-0.1
EPS Diluted
-0.07
-0.07
-0.08
-0.1
Basic Average Shares
87.21M
87.89M
82.67M
81.96M
Diluted Average Shares
87.21M
87.89M
82.67M
81.96M
EBITDA
-5.41M
-5.45M
-6.66M
-8.07M
Retained Earning Schedule
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Retained Earnings (Previous Year)
-223.75M
-217.93M
-210.94M
-202.58M
Net Income
-5.79M
-5.82M
-6.99M
-8.37M
Stock Repurchases
0
0
0
0
Dividend Paid
0
0
0
0
Retained Earnings
-229.54M
-223.75M
-217.93M
-210.94M
Other Distributions
-5.79M
-5.82M
-6.99M
-8.37M
PPE Schedule
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Gross PPE
5.03M
5.54M
5.39M
5.75M
Annual Depreciation
352.12k
341.28k
323.46k
322.07k
Capital Expenditure
-197.86k
-136.74k
-160.45k
-78.81k
Net PPE
4.87M
5.34M
5.23M
5.51M
Intangible and Goodwill Schedule
Quarter
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
